BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 35705990)

  • 1. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
    Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
    BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
    Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
    J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation.
    Bhogal B; Weir BA; Crescenzo R; Marien A; Kwon MC; Philippar U; Cowley GS
    Commun Biol; 2022 Nov; 5(1):1174. PubMed ID: 36329185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional role of DNMT3A mutation in acute myeloid leukemia].
    Koya J; Kurokawa M
    Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking of epigenetic changes during hematopoietic differentiation of induced pluripotent stem cells.
    Cypris O; Frobel J; Rai S; Franzen J; Sontag S; Goetzke R; Szymanski de Toledo MA; Zenke M; Wagner W
    Clin Epigenetics; 2019 Feb; 11(1):19. PubMed ID: 30717806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b.
    Hsieh CL
    Mol Cell Biol; 1999 Dec; 19(12):8211-8. PubMed ID: 10567546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b.
    Chen T; Ueda Y; Dodge JE; Wang Z; Li E
    Mol Cell Biol; 2003 Aug; 23(16):5594-605. PubMed ID: 12897133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations to
    Venugopal K; Feng Y; Shabashvili D; Guryanova OA
    Cancer Res; 2021 Jan; 81(2):254-263. PubMed ID: 33087320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT3A in Leukemia.
    Brunetti L; Gundry MC; Goodell MA
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 28003281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias.
    Yang L; Rodriguez B; Mayle A; Park HJ; Lin X; Luo M; Jeong M; Curry CV; Kim SB; Ruau D; Zhang X; Zhou T; Zhou M; Rebel VI; Challen GA; Gottgens B; Lee JS; Rau R; Li W; Goodell MA
    Cancer Cell; 2016 Jun; 29(6):922-934. PubMed ID: 27300438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells.
    Challen GA; Sun D; Mayle A; Jeong M; Luo M; Rodriguez B; Mallaney C; Celik H; Yang L; Xia Z; Cullen S; Berg J; Zheng Y; Darlington GJ; Li W; Goodell MA
    Cell Stem Cell; 2014 Sep; 15(3):350-364. PubMed ID: 25130491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
    Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
    J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
    Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
    Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells.
    Salazar-Roa M; Trakala M; Álvarez-Fernández M; Valdés-Mora F; Zhong C; Muñoz J; Yu Y; Peters TJ; Graña-Castro O; Serrano R; Zapatero-Solana E; Abad M; Bueno MJ; Gómez de Cedrón M; Fernández-Piqueras J; Serrano M; Blasco MA; Wang DZ; Clark SJ; Izpisua-Belmonte JC; Ortega S; Malumbres M
    EMBO J; 2020 Aug; 39(16):e104324. PubMed ID: 32614092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo DNA methylation by Dnmt3a and Dnmt3b is dispensable for nuclear reprogramming of somatic cells to a pluripotent state.
    Pawlak M; Jaenisch R
    Genes Dev; 2011 May; 25(10):1035-40. PubMed ID: 21576263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA Methylation Signatures Are Determined by DNMT3A/B Sequence Preferences.
    Mao SQ; Cuesta SM; Tannahill D; Balasubramanian S
    Biochemistry; 2020 Jul; 59(27):2541-2550. PubMed ID: 32543182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
    Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
    Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distinct loci for de novo DNA methylation by DNMT3A and DNMT3B during mammalian development.
    Yagi M; Kabata M; Tanaka A; Ukai T; Ohta S; Nakabayashi K; Shimizu M; Hata K; Meissner A; Yamamoto T; Yamada Y
    Nat Commun; 2020 Jun; 11(1):3199. PubMed ID: 32581223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing.
    Banaszak LG; Giudice V; Zhao X; Wu Z; Gao S; Hosokawa K; Keyvanfar K; Townsley DM; Gutierrez-Rodrigues F; Fernandez Ibanez MDP; Kajigaya S; Young NS
    Blood Cells Mol Dis; 2018 Mar; 69():10-22. PubMed ID: 29324392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.